AllDocs -> cancers

Cancer Mortality by Socioeconomic Status in Queensland Cancer of the Brain Meninges and other central nervous system 0 3 6 9 12 15 0 3 6 9 12 15 Male Female Rate per 100,000 population Rate per 100,000 population Avg No. Avg No. per Year per Year Mortality of Cancer of the Brain Meninges and other central nervous system, by SEIFA category and Sex, Queensland, Five Year Average, 1998 to 2002 7.3 16 4.5 11 High SES SEIFA Quintile 6.8 21 4.2 15 Mod. high SES 6.4 21 5.8 20 Moderate SES 5.8 26 4.1 19 Mod. Low SES 7.0 24 5.2 19 Low SES Note: Rates are age standardised ...

Cancer Incidence by Proportion Indigenous Population in Queensland Cancer of the Brain Meninges and other central nervous system 0 3 6 9 12 15 0 3 6 9 12 15 Male Female Rate per 100,000 population Rate per 100,000 population Avg No. Avg No. per Year per Year Incidence of Cancer of the Brain Meninges and other central nervous system, by Indigenous Proportion and Sex, Queensland, Five Year Average, 1998 to 2002 8.7 131 6.3 102 <5% Indigenous Proportion Indigenous Population 6.7 12 4.8 8 At least 5% Indigenous Note: Rates are age standardised to the Australian population as at 30 June 2001. Numbers and rates are averaged over five years, and based on place of usual residence at time ...

Imaging Endogenous Gene Expression in Brain Cancer In Vivo with 111 In-Peptide Nucleic Acid Antisense Radiopharmaceuticals and Brain Drug-Targeting Technology Toyofumi Suzuki, PhD 1 ; Dafang Wu, MD, PhD 2 ; Felix Schlachetzki, MD 3 ; Jian Yi Li, MD, PhD 4 ; Ruben J. Boado, PhD 4 ; and William M. Pardridge, MD 4 1 College of Pharmacy, Nihon University, Chiba, Japan; 2 Department of Radiology, Wayne State University, Detroit, Michigan; 3 Department of Neurology, Regensburg University, Regensburg, Germany; and 4 Department of Medicine, UCLA, Los Angeles, California Imaging endogenous gene expression with sequence-specific antisense radiopharmaceuticals is possible if the antisense agent is enabled to traverse the biologic ...

Molecular Imaging of Pediatric Brain Cancer Raymond W. Sze, M.D. Assistant Professor of Radiology Page 2 Outline of Talk • Why is Pediatric Brain Cancer Important? • What advances are being made in Pediatric Brain Cancer Research? • What is Molecular Imaging? • What are “smart” nanoparticle contrast agents? • How can we use these agents for Pediatric Brain Cancer ? Page 3 I. Why is Pediatric Brain Cancer Important? Page 4 Pediatric Brain Cancer • Most common solid tumor in children • 1700 new diagnosis in USA • 20% of all childhood cancer deaths • Medulloblastoma is most common type of Pediatric Brain Cancer Page ...

16 th EORTC – NCI – AACR Symposium on Molecular Targets and Cancer Therapeutics Geneva, Switzerland, 28 September – 1 October 2004 Conference secretariat: EORTC-NCI-AACR 2004, FECS – Federation of European Cancer Societies Avenue E. Mounier 83, B-1200 Brussels T: +32 (0) 2 775 02 01 – F: +32 (0) 2 775 02 00 – E-mail: ENA2004@fecs.be – www.fecs.be Embargoed: 12.30 hrs CET Wednesday 29 September 2004 Trial shows which brain cancer patients benefit from temozolomide Genetic predictive test clears way for targeted drug treatment Geneva, Switzerland: An international team of scientists and cancer specialists has identified which patients with the deadly form of brain tumours called glioblastomas are likely to live longer if they are treated with temozolomide, and which patients are likely to get only marginal, if any, benefit. The genetic predictive test on ...

www.calgaryhealthregion.ca November 23, 2004 Issue #123 Our people. Our work. Our values. TACKLING INFLUENZA 2 MEN’S HEALTH DAY 3 s the plane carrying Jo O’Callaghan prepared to land at Baghdad airport in April 2003, the pilot issued a polite warning. “Our pilot told us to brace our- selves for our arrival in Baghdad, but I could never have been prepared for such an emo- tionally challenging experience,” the Calgary Health Region nurse said. “Even though we hear reports, you can never be prepared for the effect years of instabil- ity, violence and devastation has had on the people. They have nothing – less than noth- ing – every time I turned around I was on the brink of tears.” An Emergency Department nurse at the Oilfields Hospital in Black Diamond, O’Callaghan was one of four Red Cross delegates ...

Cancer Incidence by Remoteness Category in Queensland Cancer of the Brain Meninges and other central nervous system 0 3 6 9 12 15 0 3 6 9 12 15 Male Female Rate per 100,000 population Rate per 100,000 population Avg No. Avg No. per Year per Year Incidence of Cancer of the Brain Meninges and other central nervous system, by ARIA Category and Sex, Queensland, Five Year Average, 1997 to 2001 9.0 104 6.4 81 Highly accessible ARIA Category 8.3 19 6.3 14 Moderately accessible 7.4 13 5.8 10 Accessible 10.3 4 7.5 3 Remote 7.6 2 5.7 1 Very remote Note: Rates are age standardised ...

Brain Cancer Rates for White Males 1955 - 1984 Ashley A. Talley Geog 321 10.7.2004 Atlas of Cancer Mortality in the United States 1950 - 1994 1970-1974 Standard Deviation < -2.5 -2.5 - -1.5 -1.5 - -0.5 -0.5 - 0.5 0.5 - 1.5 1.5 - 2.5 > 2.5 1980-1984 Standard Deviation < -2.5 -2.5 - -1.5 -1.5 - -0.5 -0.5 - 0.5 0.5- 1.5 1.5 - 2.5 > 2.5 1960-1964 Standard Deviation < -2.5 -2.5 - -1.5 -1.5 - -0.5 -0.5 - 0.5 0.5 - 1.5 1.5 - 2.5 > 2.5 1955-1959 Standard Deviation < -2.5 -2.5 - -1.5 -1.5 - -0.5 -0.5 - 0.5 0.5 - 1.5 1.5 - 2.5 > 2.5

USSEA Number of deaths per 100,000 person-years 1.0419 - 2.0000 2.0001 - 4.0000 4.0001 - 6.0000 6.0001 - 8.0000 8.0001 - 12.0000 0 750 1,500 Miles Data from Atlas of Cancer Mortality in the United States (1950-1994) Rates among White Males, 1980-84 Rates among Black Males, 1980-84 Rates among White Males, 1990-94 Rates among Black Males, 1990-94 0 750 1,500 Miles 0 750 1,500 Miles 0 750 1,500 Miles USSEA Number of deaths per 100,000 person-years 0.0000 - 2.0000 2.0001 - 4.0000 4.0001 - 6.0000 6.0001 - 8.0000 8.0001 - 10.0000 10.0001 - 52.1303 USSEA Number of deaths per 100,000 person-years 1.4932 - 2.0000 2.0001 - 4.0000 4.0001 - 5.8858 5.8859 - 6.6942 6.6943 - 10.0000 10.0001 - 10.9667 USSEA Number ...

Rates among White Males, 1980-84 Rates among Black Males, 1980-84 Rates among White Males, 1990-94 Rates among Black Males, 1990-94 0 700 1,400 Miles Data from Atlas of Cancer Mortality in the United States (1950-1994) 0 700 1,400 Miles 0 700 1,400 Miles 0 700 1,400 Miles USSEA Number of deaths per 100,000 person-years 1.0-3.2 3.2-4.3 4.3-5.2 5.2-6.2 6.2-7.6 7.6-11.9 USSEA Number of deaths per 100,000 person-years 0 0.1-1.8 1.8-2.6 2.6-3.2 3.2-4.1 4.1-6.2 6.2-52.1 USSEA Number of deaths per 100,000 person-years 1.5-2.3 2.3-3.6 3.6-4.9 4.9-6.2 6.2-7.5 7.5-8.8 8.8-11.0 USSEA Number of deaths per 100,000 person-years 0 0.1-2.1 2.1-3.1 3.1-4.0 4.0-6.2 ...

The Sontag Foundation Awards $1.5 million for Brain Cancer Medical Research (Ponte Vedra Beach, Florida), September 9, 2004- The Sontag Foundation announces the presentation of three Distinguished Scientist Awards totaling $1.5 million. Each of the three recipients of the award will receive $500,000 funding over a three-year period to support their medical research. Through The Distinguished Scientist Award, The Sontag Foundation seeks to recognize and support the work of outstanding early career scientists in this country whose research has the potential to generate new knowledge relating to the causes, cures or treatmens of brain tumors. The Distinguished Scientist Awards for 2004 were presented to the following scientists: Dr. Anita Lal at University of California, San Francisco, Dr. Mark Johnson at Brigham & Women’s Hospital in Boston, and Dr. Cynthia Wetmore at Mayo Clinic in Rochester. In response ...

288 www.SupportiveOncology.net T HE J OURNAL OF S UPPORTIVE O NCOLOGY O B S E R V A T I O N S New Study to Probe Effects of Methionine on Brain Cancer T he Cancer Treatment Research Foundation (CTRF) has an- nounced that it is funding a 2-year studyinvestigatingwhethertheelimina- tion of the amino acid methionine from the diet, coupled with chemotherapy, provides increased survival for patients suffering from glioblastoma multiforme. Morris D. Groves, MD, Assistant Professor of Neuro-Oncology at The University of Texas M. D. Anderson Cancer Center, Houston, will conduct the study, which will treat patients with standard chemotherapy combined with a special methionine-free diet. The diet alone should cause some tumor cells to die, but when the diet is combined with chemotherapy, ...

Inhibition of breast and brain cancer cell growth by BCCIP a , an evolutionarily conserved nuclear protein that interacts with BRCA2 Jingmei Liu 1 , Yuan Yuan 1,2 , Juan Huan 2 and Zhiyuan Shen* ,1 1 Department of Molecular Genetics and Microbiology, University of New Mexico Health Sciences Center; 915 Camino de Salud, NE. Albuquerque, New Mexico, NM 87131, USA; 2 Graduate Program of Molecular Genetics, College of Medicine, University of Illinois at Chicago, 900 S. Ashland Ave. Chicago, Illinois, IL 60607, USA BRCA2 is a tumor suppressor gene involved in mammary tumorigenesis. Although important functions have been assigned to a few conserved domains of BRCA2, little is known about the longest internal conserved domain encoded by exons 14 ± 24. We identi®ed a novel protein, designated BCCIP ...

Rachel's Environment & Health News #520 - Brain Cancer Update November 13, 1996 In the U.S., brain cancer has been steadily increasing about 0.7% per year since 1973. This steady increase is noteworthy by itself. However, among people over age 65, brain cancer has been increasing 2.9% each year, an astonishingly rapid rise in a cancer that is almost always fatal in the elderly. At this rate, the disease is doubling every 23 years among the elderly. Today roughly 17,500 Americans (9600 males, 7900 females) are diagnosed with new brain cancers each year.[1] During the period 1973-1990 brain cancer steadily increased in other industrialized countries as well, especially among the elderly.[2] Naturally the question arises, are these increases real or do they simply reflect better diagnosis? Several careful studies of this question have concluded that much of the increase ...

Blind recovery of biochemical markers of brain cancer in MRSI Shuyan Du a , Xiangling Mao b , Dikoma Shungu b and Paul Sajda a a Department of Biomedical Engineering, Columbia University, New York, NY USA b Department of Radiology, Mount Sinai School of Medicine, New York, NY USA ABSTRACT We present an algorithm for blindly recovering constituent source spectra from magnetic resonance spectroscopic imaging (MRSI) of human brain . The algorithm is based on the non-negative matrix factorization (NMF) algorithm, 1, 2 extending it to include a constraint on the positivity of the amplitudes of the recovered spectra and mixing matrices. This positivity constraint enables recovery of physically meaningful spectra even in the presence of noise that causes a significant number of the observation amplitudes to be negative. ...

Researchers Search for Causes of Brain Cancer National Brain Tumor Foundation sponsors groundbreaking international research consortium in search for causes of brain tumors. San Francisco, CA (PRWEB) February 19, 2005 -- Cell phones, power lines, and diet have all been investigated as possible causes of brain tumors yet definitive answers continue to elude scientists. Each year, the public interest in wanting to know the causes of cancer grow yet research has been slow in finding answers. As a way of increasing our understanding of brain tumors and focusing more attention on causes, the National Brain Tumor Foundation is supporting a new international consortium of brain tumor researchers who hope to combine forces to better answers the question “What Causes Brain Tumors?” The purpose of this group, named the BTEC or the Brain Tumor Epidemiology Consortium, is to develop multi-center collaborations ...

Complete Response of Brain Metastases Originating in Breast Cancer to Capecitabine Therapy Nava Siegelmann-Danieli MD 1 , Moshe Stein MD 2 and Jacob Bar-Ziv MD 3 1 Department of Hematology and Oncology, Geisinger Medical Center, Danville, PA, USA 2 Department of Oncology, Rambam Medical Center, Haifa, Israel 3 Department of Radiology, Hadassah University Hospital, Jerusalem, Israel Key words: brain metastases, breast cancer , capecitabine, performance status, ascites IMAJ 2003;5:833-834 Brain metastatses are often pre-terminal events in patients with solid cancers; median survival is only a few months. We report the case of a heavily pretreated breast cancer patient who developed brain metastases along with ascites due to profound liver involvement. Symptoms ...

Journal of the National Cancer Institute, Vol. 95, No. 20, 1548-1551, October 15, 2003 DOI: 10.1093/jnci/djg072 © 2003 Oxford University Press Shared Genetic Susceptibility to Breast Cancer , Brain Tumors, and Fanconi Anemia Kenneth Offit, Orna Levran, Brian Mullaney, Katherine Mah, Khedoudja Nafa, Sat Dev Batish, Raffaella Diotti, Hildegard Schneider, Amie Deffenbaugh, Thomas Scholl, Virginia K. Proud, Mark Robson, Larry Norton, Nathan Ellis, Helmut Hanenberg, Arleen D. Auerbach Affiliations of authors: K. Offit, K. Mah, K. Nafa, M. Robson, N. Ellis (Clinical Genetics Service), L. Norton (Breast Cancer Medicine Service), Memorial Sloan-Kettering Cancer Center, New York, NY; O. Levran, S. D. Batish, R. Diotti, A. D. Auerbach, Laboratory of Human Genetics and Hematology, The Rockefeller University, New York; B. Mullaney, A. Deffenbaugh, T. Scholl, Myriad Genetic ...

Media Contact: Sandra Van Telephone: 1-800-880-2397 E-mail: sandy@vancommunications.com Oct. 1, 2003 – FOR IMMEDIATE RELEASE POSSIBLE BRAIN CANCER -AIR POLLUTION LINK TO BE STUDIED By Internationally Renowned Neurosurgeon and AQMD Foundation LOS ANGELES, CA (Oct. 1, 2003 – The Brain Tumor and Air Pollution Foundation today announced the beginning of a research project led by an internationally renowned neurosurgeon at Cedars-Sinai Medical Center to explore a possible link between brain cancer and air pollution. The study will be led by Keith Black, M.D., director of the Cedars-Sinai Maxine Dunitz Neurosurgical Institute and Division of Neurosurgery in Los Angeles. The Brain Tumor foundation recently awarded $559,250 to the research project, with funding from the South Coast Air Quality Management District (AQMD). The Cedars-Sinai investigation will examine biochemical and pathological changes ...

Vol. 7, No. 4 February 9, 2001 New USC neuro-oncologist seeks new ways to fight brain cancer The story seems apocryphal, she ad- mits. When Kathleen Squires was a little girl growing up overseas in places like Indonesia, she saw people around her with elephantiasis—enlarged, bulging legs due to lymphatic infection—and asked her dad why they suffered from the deforming condition. “They don’t have good medical care,” he explained. And so, though no one in her family worked in medicine, she decided she would be a doctor. Today, she is one of the newest medi- cal faculty members of the Keck School of Medicine of USC, focusing on infec- tious diseases. Specifically, Squires— visiting associate professor of medi- cine—treats patients with HIV and AIDS and performs research on drugs that might better help such patients. She also logs long ...

Brain Cancer survival, incidence and mortality in NSW 1994–2000 54 The Cancer Council NSW Brain cancer • The five-year relative survival from brain cancer in NSW between 1994 and 2000 was 18.4% • No Area Health Service was different from the State average in the adjusted relative risk of excess death after shrinking • An additional 44 patients would be expected to survive to five years after diagnosis in NSW if the State average risk was shifted to the 20 th centile of the distribution • There were 2,073 new cases of brain cancer in NSW in 1994 to 1998 (1,198 males and 875 females) and 1,637 deaths (950 males and 687 females) • There were no Area Health Services in which the number of new cases or deaths from brain cancer was different from expected in males • There was no area variation in the excess number of new cases or deaths in females ...

Abstract. Although conventional chemotherapies are used to treat patients with malignancies, damage to normal cells is problematic. Blood-forming bone marrow cells are the most adversely affected. It is therefore necessary to find alternative agents that can kill cancer cells but have minimal effects on normal cells. We investigated the brain cancer cell-killing activity of a homeopathic medicine, Ruta, isolated from a plant, Ruta graveolens . We treated human brain cancer and HL-60 leukemia cells, normal B-lymphoid cells, and murine melanoma cells in vitro with different concentrations of Ruta in combination with Ca 3 (PO 4 ) 2 . Fifteen patients diagnosed with intracranial tumors were treated with Ruta 6 and Ca 3 (PO 4 ) 2 . Of these 15 patients, 6 of the 7 glioma patients showed complete ...

5 Jul 2003 No. 55 H I G H L I G H T S MMR vaccine safety debate continues 3 Preradiation chemotherapy superior for paediatric brain cancer 5 CONTENTS Adderall vs SLI 381 for paediatric ADHD 4 ADHD treatment not associated with growth deficits in girls 10 Amodiaquine (intermittent) reduces malarial fevers, anaemia in infants 7 Amoxicillin/clavulanic acid in febrile neutropenia 6 Anaesthesia: which strategy worth it for day surgery in the UK? 8 Autoimmune disease: are vaccines a potential cause? 4 Azithromycin superior to cefixime in bacillary dysentery 5 Breast milk antidepressant exposure does not impair infants’weight gain 10 Cefadroxil vs linezolid in paediatric skin infections 5 Cefixime vs azithromycin in bacillary dysentery 5 Chemotherapy (preradiation) ...

Center for Environmental Health Studies (617) 482-9485 44 Farnsworth Street, Boston, MA 02210 http://www.jsi.com * Findings were statistically significant (strong evidence) + Evidence of a dose-response relationship (strongest evidence) Page 21 Brain Cancer and Exposure to Ionizing Radiation Summary: There is strong evidence that brain cancer may be associated with exposure to ionizing radiation. This evidence is based upon studies conducted at Los Alamos National Laboratory, studies of nuclear workers at other sites, and others exposed to ionizing radiation. This is consistent with the National Research Council’s finding that brain tissue is sensitive to ionizing radiation. There remains some scientific debate as to whether brain cancer in nuclear workers may be due to radiation or chemical exposures. Brain cancer is ...

Adjunctive Nutritional & Botanical Treatment for Brain Cancer : Best Case Series Jeanne M. Wallace, PhD, CNC Clinical Nutrition Consultant Nutritional Solutions, Inc. Goals of Adjuvant Nutritional and Botanical Support Complement medical treatments Enhance efficacy Mitigate side effects, enhance quality of life (QOL) Offer support between treatment cycles Target inflammatory cytokines Impede angiogenesis Promote differentiation, apoptosis (cell death) Bolster immune function Dietary Modifications General Diet Guidelines •Increase vegetable servings to 5-7/day; increase fruits to 2 servings/day •Dietary fats @30%/Kcal intake; increase n-3, decrease n-6 fats; emphasize fish, flax, olive oils; eliminate fried foods, hydrogenated or trans fats •Balance blood glucose levels: increase complex carbs, fiber; decrease simple sugars (high Glycemic ...

1 Brain Cancer and Magnetic Resonance Spectroscopy Jeffry R. Alger, PhD Department of Radiological Sciences Jonsson Comprehensive Cancer Center Brain Research Institute Ahmanson-Lovelace Brain Mapping Center University of California, Los Angeles I. Introduction II. MRS fundamentals in relation to brain cancer III. The MRS appearance of brain tumors IV. Clinical uses of MRS for brain tumor management V. Summary VI. Glossary VII. Bibliography I. Introduction Brain cancer has been studied with Magnetic Resonance Spectroscopy (MRS) for approximately the past ten years. This research is now leading to the regular use of MRS for the routine clinical evaluation of brain cancer patients. This article will summarize the present state of knowledge related to MRS and brain cancer and illustrate likely future areas of development and application. ...

statistics Brain Cancer Source: PENN State - Graduate Student Research Statistics: PA Department of health, Bureau of Health Statistics ( 2001, August) Analysis of cancer incidence in PA counties 1994-1998 1999 Brain Cancer Statistics (Ages 15 and above) Tri County Area Cases per 100,000 Montgomery County 73 10.08 Berks County 35 9.77 Chester County 22 5.12 1999 (Ages 15 and above) Montgomery County has the HIGHEST RATE of brain cancer by a large margin compared to: U.S., PA, and Tioga County in PA ( a less polluted county for comparison) Brain Cancer in Montgomery County (1995 to 1999) almost DOUBLED in only 5 years Montgomery County Brain Cancer 1995 5.80 per 100,000 1999 10.08 per 100,000 1999 Brain Cancer Statistics - Pottstown Brain Cancer Rate per 100,000 in Pottstown - 9.25 ¯ This is SIGNIFICANTLY HIGHER than the State and National ...

Abstract. The purpose of this study was to estimate the risk of thyroid cancer induction attributable to brain radiation therapy in adult and pediatric patients. An anthropomorphic phantom was used to simulate treatment of brain tumors with two lateral opposed fields. Thyroid dose was measured using thermo- luminescent dosimeters. Phantom measurements were per- formed for all possible field sizes that may be applied during brain radiotherapy in adults and children. The dependence of the thyroid dose on the distance from the irradiation field and on the presence of beam modifiers in the primary beam was investigated. All phantom exposures were generated with a 6 MV photon beam. Thyroid dose was found to vary from 9.6 to 89.4 cGy and from 8.0 to 194.0 cGy depending upon the field size used and the thyroid location in respect to the field edge for adults and children respectively. The excess relative ...

NUMERICAL SIMULATION OF EM ABSORPTION FOR A PATIENT WITH BRAIN CANCER Ae-kyoung Lee (1) , Hyung-do Choi (2) , Done-sik Yoo (3) , Hyung-soo Lee (4) , Jeong-ki Pack (5) (1) Radio Science Dept., Electronics and Telecommunications Research Institute, 161 Gajong-Dong, Yusong-Gu, 305-350, Daejon, Korea, E-mail: aklee@etri.re.kr (2) As (1) above, but E-mail: choihd@etri.re.kr (3) As (1) above, but E-mail: dsyoo@etri.re.kr (4) As (1) above, but E-mail: hsulee@etri.re.kr (5) Dept. of Radio Science and Engineering, Chungnam National University, 220 Kung-Dong, Yu- song-Gu, 305-764, Daejon, Korea, E-mail: jkpack@hanbat.cnu.ac.kr ABSTRACT The electromagnetic absorptions in the normal model and the patient models ...